Table 1.

Baseline demographics and glaucoma medications for open-angle glaucoma patients of African and European descent

	African Descent	European Descent
Total participants	29	83
Average Age (SD)	63 (±11)	65 (±11)
Age ≥ 65	15	47
Male	8	36
Non-insulin dependent diabetes mellitus	4	17
BMI ≥ 25	24	50
Hypertension medication use	13	38
Intraocular Pressure (SD)	16.9 (±3.8)	15.9 (±4.5)
Glaucoma medications*
Carbonic anhydrase inhibitors (e.g. Dorzolamide)	8	11
Prostaglandin analogues (e.g. Latanoprost)	15	53
α adrenergic agonist (e.g. Brimonidine)	8	13
Beta receptor blockers (e.g. Timolol)	13	21

^*Patients may be using more than one glaucoma medication

Note: There was no significant difference between AD and ED patients regarding a history of hypertension, hyperlipidemia, cardiovascular disease, family history of cardiovascular disease, smoking status, diabetes, or use of carbonic anhydrase inhibitors, prostaglandin analogues, α adrenergic agonist, or beta receptor blockers (p>0.05).

Table 1 legend: SD-standard deviation; BMI-body mass index